Stock Research for AXIM


Featured Broker: Ally Invest

Get the due diligence for another stock.


AXIM Stock Chart & Research Data

The AXIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AXIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


AXIM Due diligence Resources & Stock Charts

The AXIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AXIM Detailed Price Forecast - CNN Money CNN View AXIM Detailed Summary - Google Finance
Yahoo View AXIM Detailed Summary - Yahoo! Finance Zacks View AXIM Stock Research & Analysis -

Stock Analysis

TradeIdeas View AXIM Trends & Analysis - Trade-Ideas Barrons View AXIM Major Holders - Barrons
NASDAQ View AXIM Call Transcripts - NASDAQ Seeking View AXIM Breaking News & Analysis - Seeking Alpha
Spotlight View AXIM Annual Report - OTC Report View AXIM OTC Short Report -
TradeKing View AXIM Fundamentals - TradeKing Charts View AXIM SEC Filings - Bar Chart
WSJ View Historical Prices for AXIM - The WSJ Morningstar View Performance/Total Return for AXIM - Morningstar
MarketWatch View the Analyst Estimates for AXIM - MarketWatch CNBC View the Earnings History for AXIM - CNBC
StockMarketWatch View the AXIM Earnings - StockMarketWatch MacroAxis View AXIM Buy or Sell Recommendations - MacroAxis
Bullish View the AXIM Bullish Patterns - American Bulls Short Pains View AXIM Short Pain Metrics -

Social Media Mentions

StockTwits View AXIM Stock Mentions - StockTwits PennyStocks View AXIM Stock Mentions - PennyStockTweets
Twitter View AXIM Stock Mentions - Twitter Invest Hub View AXIM Investment Forum News - Investor Hub
Yahoo View AXIM Stock Mentions - Yahoo! Message Board Seeking Alpha View AXIM Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for AXIM - Insider Cow View Insider Transactions for AXIM - Insider Cow
CNBC View AXIM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AXIM - OTC Markets
Yahoo View Insider Transactions for AXIM - Yahoo! Finance NASDAQ View Institutional Holdings for AXIM - NASDAQ

Stock Charts

FinViz View AXIM Stock Insight & Charts - StockCharts View AXIM Investment Charts -
BarChart View AXIM Stock Overview & Charts - BarChart Trading View View AXIM User Generated Charts - Trading View

Latest Financial News for AXIM

CBD Company to Research Now
Posted on Tuesday April 16, 2019

HENDERSON, NV / ACCESSWIRE / April 16, 2019 / CBD is becoming a household name in the US. In a recent survey conducted with the Harris Poll, Quartz asked over 2,000 Americans about their use and perceptions ...

AXIM® Biotechnologies, Inc. Announces Attendance and Presentation by Chief Technology Officer Lekhram Changoer at Kannaway® “Believe” National Convention
Posted on Friday April 12, 2019

NEW YORK, April 12, 2019 -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today.

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Enters Services Agreement with CRO to Begin Clinical Studies on Dronabinol and CBD Chewing Gums
Posted on Wednesday April 10, 2019

SAN DIEGO , April 10, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced that its investment company AXIM® Biotechnologies ...

AXIM® Biotech Enters Services Agreement With CRO to Begin Clinical Studies On Dronabinol and CBD Chewing Gums
Posted on Tuesday April 09, 2019

AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a Services Agreement with contract research organization (“CRO”) QPS Netherlands BV, a global leader in contract research, to begin separate bio comparison studies with its two leading drug candidates, MedChew® with dronabinol and CanChew® Rx. The CRO will conduct a two open label single dose studies (varying chew duration and concentration) followed by a double-blind, randomized, multiple dose study to test the bioavailability of dronabinol in MedChew®. MedChew® formulated with dronabinol is intended for treatment of chemotherapy-induced nausea and vomiting in cancer and AIDS patients.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.